| 6974- | Form, | Formononetin Defeats Multidrug-Resistant Cancers by Induction of Oxidative Stress and Suppression of P-Glycoprotein |
| - | in-vitro, | Cerv, | HeLa |
| 6975- | Form, | Formononetin inhibits colorectal cancer via the miR-490-3p/ABCC2 axis and synergizes with 5-fluorouracil: mechanistic insights and therapeutic implications |
| - | vitro+vivo, | CRC, | NA |
| 8303- | FS, | The relative bioavailability of enterolignans in humans is enhanced by milling and crushing of flaxseed |
| - | Trial, | Nor, | NA |
| 8315- | FS, | Pilot study to explore effects of low-fat, flaxseed-supplemented diet on proliferation of benign prostatic epithelium and prostate-specific antigen |
| - | Trial, | Pca, | NA | - | Trial, | BPH, | NA |
| 8313- | FS, | Flaxseed and its lignan and oil components: can they play a role in reducing the risk of and improving the treatment of breast cancer? |
| - | Review, | BC, | NA |
| 8310- | FS, | Can flaxseed “milk” prevent anthracycline mediated cardiotoxicity in women with breast cancer (CANFLAX-BC)? |
| - | Trial, | BC, | NA |
| - | in-vivo, | BPH, | NA |
| 8307- | FS, | lign, | Efficacy and safety of a flaxseed hull extract in the symptomatic management of benign prostatic hyperplasia: a parallel, randomized, double-blind, placebo-controlled, pilot study |
| - | Trial, | BPH, | NA |
| 8300- | FS, | Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery |
| - | Trial, | Pca, | NA |
| 8306- | FS, | lign, | Flax Lignans: From Biosynthetic Regulation to Biological Activities |
| - | Review, | Nor, | NA |
| 8304- | FS, | Flaxseed-derived enterolactone is inversely associated with tumor cell proliferation in men with localized prostate cancer |
| - | Trial, | Pca, | NA |
| 8588- | FS, | Tam, | Dietary flaxseed and tamoxifen affect the inflammatory microenvironment in vivo in normal human breast tissue of postmenopausal women |
| - | in-vivo, | BC, | NA |
| 8583- | FS, | The combination of flaxseed lignans and PD-1/ PD-L1 inhibitor inhibits breast cancer growth via modulating gut microbiome and host immunity |
| - | in-vivo, | BC, | NA |
| 8584- | FS, | Anti-Oxidant and Anti-Cancer Properties of Flaxseed |
| - | Review, | Nor, | NA |
| 8581- | FS, | Dietary Modulation of the Human Gut Microbiota and Metabolome with Flaxseed Preparations |
| - | in-vivo, | Nor, | NA |
| 8580- | FS, | Anti-Cancer Properties of Flaxseed Proteome |
| - | Review, | Var, | NA |
| 8579- | FS, | IP6, | Flaxseed: a potential source of food, feed and fiber |
| - | Review, | Nor, | NA | - | Review, | IBD, | NA |
| 8578- | FS, | High alpha-linolenic acid flaxseed (Linum usitatissimum): some nutritional properties in humans |
| - | Human, | Nor, | NA |
| 8585- | FS, | Dietary flaxseed: Cardiometabolic benefits and its role in promoting healthy aging |
| - | Review, | Nor, | NA |
| 8586- | FS, | The Role of Flaxseed in Improving Human Health |
| - | Review, | Nor, | NA |
| 8587- | FS, | Rad, | Phase II Trial of Flaxseed to Prevent Acute Complications After Chemoradiation for Lung Cancer |
| - | Trial, | Lung, | NA |
| 8589- | FS, | Flaxseed Lignans as Important Dietary Polyphenols for Cancer Prevention and Treatment: Chemistry, Pharmacokinetics, and Molecular Targets |
| - | Study, | Var, | NA |
| 8590- | FS, | The Effect of Flaxseed in Breast Cancer: A Literature Review |
| - | Review, | BC, | NA |
| 8591- | FS, | doxoR, | carbop, | Flaxseed Lignans Enhance the Cytotoxicity of Chemotherapeutic Agents against Breast Cancer Cell Lines MDA-MB-231 and SKBR3 |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | SkBr3 |
| 8592- | FS, | Tras, | Flaxseed oil enhances the effectiveness of trastuzumab in reducing the growth of HER2-overexpressing human breast tumors (BT-474) |
| - | in-vitro, | BC, | BT20 |
| 8593- | FS, | Flaxseed consumption reduces blood pressure in patients with hypertension by altering circulating oxylipins via an α-linolenic acid-induced inhibition of soluble epoxide hydrolase |
| - | vitro+vivo, | Nor, | NA |
| 8594- | FS, | Consumption of flaxseed, a rich source of lignans, is associated with reduced breast cancer risk |
| - | Study, | BC, | NA |
| 8595- | FS, | Tam, | Flaxseed cotyledon fraction reduces tumour growth and sensitises tamoxifen treatment of human breast cancer xenograft (MCF-7) in athymic mice |
| - | in-vitro, | BC, | MCF7 |
| 8598- | FSO, | Tras, | Flaxseed oil-trastuzumab interaction in breast cancer |
| - | in-vivo, | BC, | NA |
| 8600- | FSO, | doxoR, | Combining doxorubicin with a phenolic extract from flaxseed oil: Evaluation of the effect on two breast cancer cell lines |
| - | in-vitro, | BC, | MCF7 |
| 8599- | FSO, | Cancer chemopreventive potential of the Egyptian flaxseed oil in a rat colon carcinogenesis bioassay--implications for its mechanism of action |
| - | in-vivo, | CRC, | NA |
| 8597- | FSO, | Chemopreventive effects of dietary flaxseed oil on colon tumor development |
| - | in-vivo, | CRC, | NA |
| 8596- | FSO, | Treatment with flaxseed oil induces apoptosis in cultured malignant cells |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | Melanoma, | B16-BL6 |
| 8609- | FSO, | Flax seed oil inhibits metastatic melanoma and reduces lung tumor formation in mice |
| - | in-vivo, | Melanoma, | NA |
| 8608- | FSO, | Cisplatin, | Flax seed oil reduced tumor growth, modulated immune responses and decreased HPV E6 and E7 oncoprotein expression in a murine model of ectopic cervical cancer |
| - | in-vivo, | Cerv, | NA |
| - | Review, | Obesity, | NA |
| 8605- | FSO, | The effect of flaxseed oil consumtion on blood pressure among patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized clinical trials |
| - | Review, | Obesity, | NA |
| - | Trial, | Diabetic, | NA |
| 8603- | FSO, | Flaxseed oil supplementation decreases C-reactive protein levels in chronic hemodialysis patients |
| - | Trial, | Nor, | NA |
| 8602- | FSO, | Supplementation with Flaxseed Oil Rich in Alpha-Linolenic Acid Improves Verbal Fluency in Healthy Older Adults |
| - | Trial, | AD, | NA |
| 8601- | FSO, | Differential Response of Two Human Breast Cancer Cell Lines to the Phenolic Extract from Flaxseed Oil |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | Nor, | MCF-10AT |
| 7010- | Fuc, | Fucoidan enhances the effect of chemotherapeutic drug against drug-resistant lung cancer cells |
| - | in-vitro, | Lung, | NA |
| 7011- | Fuc, | ATO, | VitA,RetA, | Fucoidan enhances the therapeutic potential of arsenic trioxide and all-trans retinoic acid in acute promyelocytic leukemia, in vitro and in vivo |
| - | vitro+vivo, | APL, | APL NB4 |
| 7012- | Fuc, | Fucoidan: A promising natural therapeutic agent for protecting human kidney health |
| - | Review, | EC, | NA |
| 7013- | Fuc, | Fucoidan-based nanoparticles for colorectal cancer therapy: Mechanisms and preclinical insights |
| - | Review, | CRC, | NA |
| 7014- | Fuc, | 5-FU, | Low-Molecular-Weight Fucoidan as Complementary Therapy of Fluoropyrimidine-Based Chemotherapy in Colorectal Cancer |
| - | in-vitro, | CRC, | HCT116 | - | in-vitro, | Colon, | Caco-2 |
| 7015- | Fuc, | Effects of Ingesting Fucoidan Derived from Cladosiphon okamuranus Tokida on Human NK Cells: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Pilot Study |
| - | Trial, | Nor, | NA |
| 7016- | Fuc, | Therapies from Fucoidan: New Developments |
| - | Review, | Var, | NA |
| 7017- | Fuc, | Comparative study on neuroprotective activities of fucoidans from Fucus vesiculosus and Undaria pinnatifida |
| - | in-vitro, | AD, | PC12 |
| 7026- | Fuc, | Fucoidan |
| - | Review, | AD, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid